Ketorolac Sublingual vs. Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in Children



Status:Recruiting
Conditions:Other Indications, Post-Surgical Pain, Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases, Musculoskeletal, Other
Healthy:No
Age Range:Any - 7
Updated:4/21/2016
Start Date:May 2015
Contact:Anica Crnkovic, MD
Phone:518-262-4300

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Prospective, Randomized, Allocation-Concealed, Blinded Study Designed to Compare Ketorolac Sublingual and Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in Children

The purpose of this study is to compare the efficacy and safety of ketorolac sublingual with
fentanyl intranasal used in our hospital for pain control in children undergoing bilateral
myringotomy with placement of pressure equalization tubes (BMTs).

This prospective, randomized, allocation concealed blinded study is designed to compare
ketorolac sublingual vs. fentanyl intranasal vs. the combination of these two medications
for pain control after BMTs in children. Bilateral myringotomy and tube placement is an
elective operation, mainly in the pediatric population.

Inclusion Criteria:

- American Society of Anesthesiologist (ASA) I-II physical class

- Scheduled for elective BMT

- Mask induction of anesthesia

Exclusion Criteria:

- Allergy to any NSAIDs

- Severe upper respirator infection

- Severe asthma

- Bleeding disorders

- History of GI bleeding

- Renal impairment

- Scheduled for one-sided myringotomy and tube placement
We found this trial at
1
site
Albany Medical Center
Albany, New York 12208
?
mi
from
Albany, NY
Click here to add this to my saved trials